An interesting finding is that, despite the strong role of APOE ε4 in AD risk and the relatively increased proportion of APOE ε4+ participants in the stable CVD risk group compared to the accelerated risk group, the proportion of participants developing AD was still significantly lower in the stable CVD risk group. The gene discussed is APOE; the disease is Alzheimer disease.